Vaccination of children aged 12 to 15 years with underlying health conditions

Published on: 20 September 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

Information about the end of the shielding programme and managing the closure of the Shielded Patient List

Published on: 17 September 2021
Last modified on: 16 March 2022

• Coronavirus
• COVID-19

Immediate action required for Phase 3 booster vaccinations

Published on: 15 September 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

COVID-19 vaccination for secondary school age children: governance of storage, distribution and preparation arrangements for COVID-19 vaccines by School Aged Immunisation Service teams

Published on: 15 September 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

Vaccination of healthy children and young people aged 12 to 15

Published on: 15 September 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

Asymptomatic staff testing for COVID-19 at vaccination sites

Published on: 8 September 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

Updated JCVI guidance for vaccinating immunosuppressed individuals with a third primary dose

Published on: 2 September 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

Impact of granting a Conditional Marketing Authorisation for Pfizer-BioNTech COVID-19 vaccine (Comirnaty®)

Published on: 26 August 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

Patient Group Direction for Comirnaty® 30micrograms/dose COVID-19 mRNA vaccine

Published on: 26 August 2021
Last modified on: 28 April 2022

• Coronavirus
• COVID-19

COVID-19 and seasonal flu vaccination in trusts

Published on: 19 August 2021
Last modified on: 6 September 2022

• Coronavirus
• COVID-19